CRKL expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.700000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.236000E-01
Normal-vs-Stage2
6.756800E-01
Normal-vs-Stage3
1.151630E-01
Normal-vs-Stage4
6.756800E-01
Stage1-vs-Stage2
3.758000E-01
Stage1-vs-Stage3
3.679800E-03
Stage1-vs-Stage4
6.383800E-01
Stage2-vs-Stage3
6.054400E-02
Stage2-vs-Stage4
2.949400E-01
Stage3-vs-Stage4
8.216400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.817600E-01
Normal-vs-AfricanAmerican
8.803000E-01
Normal-vs-Asian
4.599800E-01
Caucasian-vs-AfricanAmerican
5.344000E-01
Caucasian-vs-Asian
3.627400E-01
AfricanAmerican-vs-Asian
2.385800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.753800E-01
Normal-vs-Female
7.697400E-01
Male-vs-Female
7.558000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.960600E-01
Normal-vs-Age(41-60Yrs)
8.891000E-01
Normal-vs-Age(61-80Yrs)
6.948800E-01
Normal-vs-Age(81-100Yrs)
4.453200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.759200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.977600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.169000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.322100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.121800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.466400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.068400E-01
Normal-vs-Daily Drinker
1.843850E-01
Normal-vs-Weekly Drinker
5.931400E-01
Normal-vs-Occasional Drinker
9.315600E-01
Normal-vs-Social Drinker
7.947200E-01
Non Drinker-vs-Daily Drinker
3.853600E-01
Non Drinker-vs-Weekly Drinker
6.123200E-01
Non Drinker-vs-Occasional Drinker
5.149900E-02
Non Drinker-vs-Social Drinker
4.022200E-02
Daily Drinker-vs-Weekly Drinker
2.081800E-01
Daily Drinker-vs-Occasional Drinker
5.197800E-03
Daily Drinker-vs-Social Drinker
7.279600E-03
Weekly Drinker-vs-Occasional Drinker
2.235800E-01
Weekly Drinker-vs-Social Drinker
1.846640E-01
Occasional Drinker-vs-Social Drinker
6.751800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.284200E-01
Normal-vs-Grade 2
6.731000E-01
Normal-vs-Grade 3
6.918000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.217400E-01
Grade 1-vs-Grade 3
6.028400E-01
Grade 1-vs-Grade 4
4.284200E-01
Grade 2-vs-Grade 3
6.833000E-01
Grade 2-vs-Grade 4
6.731000E-01
Grade 3-vs-Grade 4
6.918000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.221200E-01
Normal-vs-NonDiabetic
7.353200E-01
Diabetic-vs-NonDiabetic
4.889200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.677200E-01
Normal-vs-NoPancreatitis
6.819400E-01
Pancreatitis-vs-NoPancreatitis
6.133600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.589800E-01
Normal-vs-N1
7.191200E-01
N0-vs-N1
8.669800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.147000E-01
Normal-vs-TP53-NonMutant
9.854400E-01
TP53-Mutant-vs-TP53-NonMutant
1.582790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
